Macimorelin Acetate

้†‹้…ธ้ฉฌ่ฅฟ็‘žๆž—

Report date: 2026/04/16 20:00:17
NMEFirst In Class

Base Information

Drug NameMacimorelin Acetate
Drug Alias Namemacimorelinum้†‹้…ธ้ฉฌๆ˜”็‘žๆž—macimorelina้†‹้…ธ็Ž›่Žซ็‘žๆž—้ฉฌ่ฅฟ็‘žๆž— +[15]ย 
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo)
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor agonists
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsGrowth hormone deficiencyCachexia
Global Approved IndicationsGrowth hormone deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2017/12/20
Country/TerritoryArmeniaUnited StatesSlovakia +[12]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCOSCIENS Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesPharmanoviaStrongbridge Biopharma PlcConsilient Health Ltd +[6]ย 
Inactive CompaniesAEterna Zentaris GmbH
Active IndicationsGrowth hormone deficiencyCachexia
Inactive IndicationsN/A

Other Information

ATC CodeV04CD06
Related LinksWikipediaKEGG